← Back to headlines
Immunic Secures $400 Million Funding for Commercial Development
Immunic has successfully secured $400 million in funding to support the commercial-stage development of its projects. This capital injection will aid in advancing its pipeline.
16 Feb, 10:48 — 16 Feb, 10:48